PubRank

Isabelle Bairati

Author PubWeight™ 36.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 2008 2.33
2 PSA screening and prostate cancer mortality. CMAJ 2002 1.98
3 Systematic review of the literature on characteristics of late-talking toddlers. Int J Lang Commun Disord 2008 1.72
4 Health-related quality of life as a survival predictor for patients with localized head and neck cancer treated with radiation therapy. J Clin Oncol 2009 1.70
5 Antihypertensive drug use and the risk of prostate cancer (Canada). Cancer Causes Control 2004 1.63
6 Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys 2002 1.22
7 Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trial. Int J Cancer 2005 1.19
8 Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients. Int J Cancer 2008 1.18
9 Professional patient navigation in head and neck cancer. Semin Oncol Nurs 2009 1.10
10 Dosage, duration and timing of nonsteroidal antiinflammatory drug use and risk of prostate cancer. Int J Cancer 2003 1.06
11 Predictors of severe acute and late toxicities in patients with localized head-and-neck cancer treated with radiation therapy. Int J Radiat Oncol Biol Phys 2011 1.04
12 Predictors of weight loss during radiotherapy in patients with stage I or II head and neck cancer. Cancer 2010 1.03
13 Genetic polymorphisms and head and neck cancer outcomes: a review. Cancer Epidemiol Biomarkers Prev 2008 1.02
14 p53 and Ki-67 as markers of radioresistance in head and neck carcinoma. Cancer 2002 1.02
15 Serum prognostic markers in head and neck cancer. Clin Cancer Res 2010 1.01
16 Role of immunohistochemical overexpression of matrix metalloproteinases MMP-2 and MMP-11 in the prognosis of death by ovarian cancer. Am J Clin Pathol 2008 1.00
17 Implementing the role of patient-navigator nurse at a university hospital centre. Can Oncol Nurs J 2006 1.00
18 Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma. Am J Surg 2005 0.95
19 A prospective study of the insulin-like growth factor axis in relation with prostate cancer in the SU.VI.MAX trial. Cancer Epidemiol Biomarkers Prev 2005 0.92
20 Dietary vitamin D intake and serum 25-hydroxyvitamin D level in relation to disease outcomes in head and neck cancer patients. Int J Cancer 2010 0.92
21 Immunohistochemical analysis of possible chemoresistance markers identified by micro-arrays on serous ovarian carcinomas. Mod Pathol 2008 0.90
22 Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer. Mol Oncol 2011 0.89
23 Prognostic significance of cyclooxygenase-2 overexpression in glottic cancer. Clin Cancer Res 2008 0.86
24 Impact of a meaning-centered intervention on job satisfaction and on quality of life among palliative care nurses. Psychooncology 2009 0.85
25 Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin Cancer Res 2011 0.84
26 Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers. Cancer 2011 0.83
27 Three profiles of language abilities in toddlers with an expressive vocabulary delay: variations on a theme. J Speech Lang Hear Res 2010 0.83
28 Acute adverse effects of radiation therapy and local recurrence in relation to dietary and plasma beta carotene and alpha tocopherol in head and neck cancer patients. Nutr Cancer 2007 0.82
29 Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int J Cancer 2012 0.81
30 Human epididymis protein 4 (HE4) and ovarian cancer prognosis. Gynecol Oncol 2012 0.81
31 A cosmetic evaluation of breast cancer treatment: a randomized study of radiotherapy boost technique. Int J Radiat Oncol Biol Phys 2005 0.81
32 Factors associated with weight loss during radiotherapy in patients with stage I or II head and neck cancer. Support Care Cancer 2011 0.81
33 Green tea for ovarian cancer prevention and treatment: a systematic review of the in vitro, in vivo and epidemiological studies. Gynecol Oncol 2012 0.80
34 A two-stage, single-arm, phase II study of EGCG-enriched green tea drink as a maintenance therapy in women with advanced stage ovarian cancer. Gynecol Oncol 2013 0.79
35 Prostatic intraepithelial neoplasia in TURP specimens and subsequent prostate cancer. Can J Urol 2006 0.75